Effect of risedronate combined with vitamin K2 in patients with osteoporosis due to the steroid therapy

Trial Profile

Effect of risedronate combined with vitamin K2 in patients with osteoporosis due to the steroid therapy

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Oct 2014

At a glance

  • Drugs Risedronic acid (Primary) ; Vitamin K2 (Primary) ; Vitamin K
  • Indications Corticosteroid-induced osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top